Radiotherapeutic management of adult intraspinal ependymomas
- PMID: 3082807
- DOI: 10.1016/0360-3016(86)90345-7
Radiotherapeutic management of adult intraspinal ependymomas
Abstract
Twenty-two adults with ependymomas of the spinal cord were treated with surgery and postoperative radiation between January 1963 and December 1983. The median age was 47 years. Nineteen patients had grade 1 lesions, two had grade 2 and one grade 3. Ten patients had the myxopapillary histologic subtype (all grade 1) and 12 had the cellular variant. There were 15 distal cord lesions originating from the conus medullaris, filum terminale and/or cauda equina. The remaining seven lesions arose more proximally. Fourteen patients had localized lesions involving one to three vertebral segments, while the remaining eight had extensive ependymomas spanning six to thirteen vertebral segments. The median time from onset of symptoms to diagnosis was 3 years. Surgical treatment consisted of biopsy only in three patients, subtotal removal in eleven patients and total removal in eight patients. Radiation was given to the spine only in all cases. Five patients received whole spine radiation; seventeen received partial spine treatment, appropriate for the length of the primary lesion. The median dose was 5000 cGy (range 3600-5700 cGy). The disease free survival at 5 and 10 years was 81 and 71%, respectively. Overall survival at 5 and 10 years was 95%. Seven of twenty-two (32%) patients failed. Factors analyzed for prognostic significance included age, sex, histology, extent of primary, location of primary within the cord, extent of surgical resection and dose. Too few grade 2 and 3 patients precluded meaningful statistical analysis of grade as a prognostic factor. Neither age, sex, histology, extent of primary, location of primary, nor extent of surgical removal significantly affected disease free or overall survival (p greater than 0.05). Four of nineteen (21%) patients with grade 1 lesions failed, while all three patients with grade 2 and 3 lesions did so. Half of the eight patients with extensive ependymomas failed compared to three of fourteen (21%) with limited ones. Six of seventeen (35%) patients failed at doses less than or equal to 5000 cGy while only one of five (20%) failed at doses greater than 5000 cGy. Patterns of failure were analyzed for the seven patients who failed. Six of the seven failures (86% of the failure group, 27% of the overall group) were local, that is, within the initial radiation field at the site of the original tumor. A single patient (grade 2) failed in the posterior fossa while remaining NED in the spinal cord (a head CT scan at initial work-up was negative).(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Postoperative radiotherapy of intracranial ependymoma in pediatric and adult patients.Int J Radiat Oncol Biol Phys. 1987 Oct;13(10):1457-62. doi: 10.1016/0360-3016(87)90310-5. Int J Radiat Oncol Biol Phys. 1987. PMID: 3624024
-
Surgical outcomes in spinal cord ependymomas and the importance of extent of resection in children and young adults.J Neurosurg Pediatr. 2014 Apr;13(4):393-9. doi: 10.3171/2013.12.PEDS13383. Epub 2014 Feb 7. J Neurosurg Pediatr. 2014. PMID: 24506340
-
Postoperative radiotherapy in the management of spinal cord ependymoma.J Neurosurg. 1991 May;74(5):720-8. doi: 10.3171/jns.1991.74.5.0720. J Neurosurg. 1991. PMID: 2013772
-
Prognosis by tumor location in adults with spinal ependymomas.J Neurosurg Spine. 2013 Mar;18(3):226-35. doi: 10.3171/2012.12.SPINE12591. Epub 2013 Jan 11. J Neurosurg Spine. 2013. PMID: 23311515 Review.
-
Ependymoma: results, prognostic factors and treatment recommendations.Int J Radiat Oncol Biol Phys. 1998 Mar 1;40(4):845-50. doi: 10.1016/s0360-3016(97)00893-6. Int J Radiat Oncol Biol Phys. 1998. PMID: 9531369 Review.
Cited by
-
Factors associated with postoperative outcomes in patients with intramedullary Grade II ependymomas: A Systematic review and meta-analysis.Medicine (Baltimore). 2019 Jun;98(25):e16185. doi: 10.1097/MD.0000000000016185. Medicine (Baltimore). 2019. PMID: 31232977 Free PMC article.
-
Spinal ependymoma in adults: from molecular advances to new treatment perspectives.Front Oncol. 2023 Nov 24;13:1301179. doi: 10.3389/fonc.2023.1301179. eCollection 2023. Front Oncol. 2023. PMID: 38074692 Free PMC article. Review.
-
Temozolomide for malignant primary spinal cord glioma: an experience of six cases and a literature review.J Neurooncol. 2011 Jan;101(2):247-54. doi: 10.1007/s11060-010-0249-y. Epub 2010 Jun 5. J Neurooncol. 2011. PMID: 20526650 Review.
-
Ependymomas in adults.Curr Neurol Neurosci Rep. 2010 May;10(3):240-7. doi: 10.1007/s11910-010-0109-3. Curr Neurol Neurosci Rep. 2010. PMID: 20425040 Review.
-
EANO guidelines for the diagnosis and treatment of ependymal tumors.Neuro Oncol. 2018 Mar 27;20(4):445-456. doi: 10.1093/neuonc/nox166. Neuro Oncol. 2018. PMID: 29194500 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources